--2024/Q4-- / 45.445M--
--2024/Q3-- / 42.355M--
Aug 8, 20242024/Q241.921M / 40.766M--
May 8, 20242024/Q140.523M / 39.143M--
Mar 13, 20242023/Q442.971M / 41.405M--
US Stock MarketDetailed Quotes
ANIK Anika Therapeutics
- 25.690
- +0.650+2.60%
Trading Aug 28 15:19 ET
380.13MMarket Cap-5077P/E (TTM)
25.830High24.995Low30.52KVolume25.050Open25.040Pre Close778.67KTurnover0.28%Turnover RatioLossP/E (Static)14.80MShares29.11552wk High1.81P/B276.91MFloat Cap16.54052wk Low--Dividend TTM10.78MShs Float75.715Historical High--Div YieldTTM3.33%Amplitude0.688Historical Low25.513Avg Price1Lot Size
Anika Therapeutics Key Stats
Anika Therapeutics Q2 2024 Earnings Date
Currency：USDAug 8, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 40.77M | 41.92M | +1.16M |
| Beat Est. | -7.98% | -5.37% | +2.83% |
| EPS | -<0.01 | -0.01 | -<0.01 |
| Miss Est. | +94.79% | +94.74% | -1.01% |
Analyst Rating
Aug 9, 2024
Anika Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Anika Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg